{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:13:12Z","timestamp":1772640792943,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["5lm0103002j0004 (B29)"],"award-info":[{"award-number":["5lm0103002j0004 (B29)"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research funding from Abbott Laboratories"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15658-3","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T03:44:25Z","timestamp":1770003865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of variations in urine laminin-\u03b32 monomer in non-muscle-invasive bladder cancer before and after transurethral resection of the bladder tumor"],"prefix":"10.1186","volume":"26","author":[{"given":"Kimito","family":"Osaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Umemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7338-8059","authenticated-orcid":false,"given":"Takashi","family":"Karashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisaku","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Koshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoharu","family":"Seiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Shuin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"15658_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, B\u00f6hle A, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71:447\u201361.","journal-title":"Eur Urol"},{"issue":"5","key":"15658_CR2","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.eururo.2006.11.025","volume":"51","author":"M H\u00f6glund","year":"2007","unstructured":"H\u00f6glund M. On the origin of syn- and metachronous urothelial carcinomas. Eur Urol. 2007;51(5):1185\u201393.","journal-title":"Eur Urol"},{"key":"15658_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1349-7006.2006.00150.x","volume":"97","author":"K Miyazaki","year":"2006","unstructured":"Miyazaki K. Laminin-5 (laminin-332): unique biological activity and role in tumor growth and invasion. Cancer Sci. 2006;97:91\u20138.","journal-title":"Cancer Sci"},{"key":"15658_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/cas.13261","volume":"108","author":"H Kiyokawa","year":"2017","unstructured":"Kiyokawa H, Yasuda H, Oikawa R, Okuse C, Matsumoto N, Ikeda H, et al. Serum monomeric laminin-\u03b32 as a novel biomarker for hepatocellular carcinoma. Cancer Sci. 2017;108:1432\u20139.","journal-title":"Cancer Sci"},{"key":"15658_CR5","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/cas.12832","volume":"106","author":"M Kamada","year":"2015","unstructured":"Kamada M, Koshikawa N, Minegishi T, Kawada C, Karashima T, Shuin T, et al. Urinary laminin-\u03b32 is a novel biomarker of non-muscle invasive urothelial carcinoma. Cancer Sci. 2015;106:1730\u20137.","journal-title":"Cancer Sci"},{"key":"15658_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-017-0109-4","volume":"5","author":"M Nakagawa","year":"2017","unstructured":"Nakagawa M, Karashima T, Kamada M, Yoshida E, Yoshimura T, Nojima M, et al. Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-\u03b32 as a promising diagnostic tool of non-muscle invasive bladder cancer. Biomark Res. 2017;5:29.","journal-title":"Biomark Res"},{"issue":"3","key":"15658_CR7","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1002\/cam4.5087","volume":"12","author":"T Karashima","year":"2023","unstructured":"Karashima T, Umemoto S, Kishida T, Osaka K, Nakagawa M, Yoshida E, et al. Clinical evaluation of urine laminin-\u03b32 monomer as a potent biomarker for non-muscle invasive bladder cancer. Cancer Med. 2023;12(3):2453\u201362.","journal-title":"Cancer Med"},{"key":"15658_CR8","first-page":"459","volume":"33","author":"T Ibuki","year":"2016","unstructured":"Ibuki T. Ethical principles in research ethics and Japanese ethical guidelines for medical and health research involving human subjects. Neurological Therapeutics. 2016;33:459\u201363.","journal-title":"Neurological Therapeutics"},{"key":"15658_CR9","unstructured":"Naito S, Morinaga S, Yamashita Y. General Rule for Clinical and Pathological Studies on Renal Pelvic, Ureteral and Bladder Cancer, 1st edition. Kanehara publisher; 2011:17\u201318."},{"key":"15658_CR10","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1998","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1998;44:837\u201345.","journal-title":"Biometrics"},{"key":"15658_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u20135.","journal-title":"Cancer"},{"key":"15658_CR12","first-page":"23","volume":"14","author":"EC Alexopoulos","year":"2010","unstructured":"Alexopoulos EC. Introduction to multivariate regression analysis. Hippokratia. 2010;14:23\u20138.","journal-title":"Hippokratia"},{"key":"15658_CR13","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1083\/jcb.148.3.615","volume":"148","author":"N Koshikawa","year":"2000","unstructured":"Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol. 2000;148:615\u201324.","journal-title":"J Cell Biol"},{"key":"15658_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0962-8924(03)00129-6","volume":"13","author":"S Schenk","year":"2003","unstructured":"Schenk S, Quaranta V. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol. 2003;13:366\u201375.","journal-title":"Trends Cell Biol"},{"key":"15658_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1158\/0008-5472.CAN-07-5269","volume":"68","author":"N Koshikawa","year":"2008","unstructured":"Koshikawa N, Minegishi T, Nabeshima K, Seiki M. Development of a new tracking tool for the human monomeric laminin-gamma 2 chain in vitro and in vivo. Cancer Res. 2008;68:530\u20136.","journal-title":"Cancer Res"},{"key":"15658_CR16","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/j.1464-410X.2009.08360.x","volume":"103","author":"Y Lotan","year":"2009","unstructured":"Lotan Y, Capitanio U, Shariat SF, Hutterer GC, Karakiewicz PI. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int. 2009;103:1368\u201374.","journal-title":"BJU Int"},{"key":"15658_CR17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1001\/jama.293.7.810","volume":"293","author":"HB Grossman","year":"2005","unstructured":"Grossman HB, Messing E, Soloway M, Tomera K, Katz G, Berger Y, et al. Detection of bladder cancer using a point-of-care proteomic assay. J Am Med Assoc. 2005;293:810\u20136.","journal-title":"J Am Med Assoc"},{"issue":"7","key":"15658_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00420-013-0916-3","volume":"87","author":"B Pesch","year":"2014","unstructured":"Pesch B, Taeger D, Johnen G, Gawrych K, Bonberg N, Schwentner C, et al. Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines. Int Arch Occup Environ Health. 2014;87(7):715\u201324.","journal-title":"Int Arch Occup Environ Health"},{"issue":"3","key":"15658_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11255-015-0921-4","volume":"47","author":"M Balci","year":"2015","unstructured":"Balci M, Tuncel A, Guzel O, Aslan Y, Sezgin T, Bilgin O, et al. Use of the nuclear matrix protein 22 bladder chek test\u2122 in the diagnosis of residual urothelial cancer before a second transurethral resection of bladder cancer. Int Urol Nephrol. 2015;47(3):473\u20137.","journal-title":"Int Urol Nephrol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15658-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15658-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:55:06Z","timestamp":1772621706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15658-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15658"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15658-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by our institutional review board (Kochi Medical School Hospital: ERB-106289; Kanagawa Cancer Center: 2019\u201322).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent and consented to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T. Yoshimura, E. Yoshida and M. Nakagawa are employees of Abbott Japan LLC. K. Inoue received patent royalties and research funds from SBI Pharmaceuticals Co., Ltd., honoraria from Chugai Pharmaceutical Co., Ltd., and endowments from Astellas Pharma Inc., Takeda Pharmaceutical Co., Ltd., MC Medical Inc. and Ono Pharmaceutical Co., Ltd. M. Seiki and N. Koshikawa received research funds from Tokyo University. N. Koshikawa, T. Karashima and T. Shuin received research funds from Abbott Japan LLC. None of the other authors have any potential conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}